-
1by Manuel Romero-Gómez, Juan Turnes, Javier Ampuero, Itziar Oyagüez, Beatriz Cuenca, Juan Gonzalez-Garcia, Belén Muñoz-Molina, Rocio Aguilar, Sandra Leal, Ramon Planas, Javier Garcia-Samaniego, Moises Diago, Javier Crespo, Jose Luis Calleja, Miguel Angel Casado, Ricard SolaGet full text
Published 2015-01-01
Article -
2by Stacey E. Lettini“... (TWiP), and This Week in Virology (TWiV). These podcasts are usually presented in a manner similar to a...”
Published 2014-08-01
Get full text
Article -
3“... public engagement with female scientists, and the live-taping of the 499th episode of the This Week...”
Get full text
Article -
4by A. V. Kravchenko, E. A. Orlova-Morozova, T. E. Shimonova, O. A. Kozyrev, F. I. Nagimova, N. G. Zaharova, E. S. Ivanova, U. A. Kuimova, A. A. Popova, O. E. Chernova, O. S. Tonkih, D. A. Gusev, A. A. Yakovlev, V. V. Pokrovsky, V. V. Bychko, N. V. Vostokova“... additional 48 weeks. High virological and immunological effectiveness maintained during the study...”
Published 2018-07-01
Get full text
Article -
5by Tarciana Grandi, Cláudia Maria Dornelles da Silva, Karine Medeiros Amaral, Paulo Dornelles Picon, Cintia Costi, Nicole Nascimento da Fré, Marilu Fiegenbaum, Christian Niel, Maria Lucia Rosa Rossetti“... genotyped. Early virological response (EVR) (12 weeks), end-of-treatment response (EOTR) (48 weeks...”
Published 2013-02-01
Get full text
Article -
6by Tarciana Grandi, Cláudia Maria Dornelles da Silva, Karine Medeiros Amaral, Paulo Dornelles Picon, Cintia Costi, Nicole Nascimento da Fré, Marilu Fiegenbaum, Christian Niel, Maria Lucia Rosa Rossetti“... genotyped. Early virological response (EVR) (12 weeks), end-of-treatment response (EOTR) (48 weeks...”
Published 2013-02-01
Get full text
Article -
7by Hee Yeon Seo, Han Ah Lee, Soon Young Ko, Joon Ho Wang, Jeong Han Kim, Won Hyeok Choe, So Young Kwon“... patients were treated with a 300-mg once-daily dose of TDF for more than 12 weeks. Virological markers...”
Published 2017-06-01
Get full text
Article -
8by Rupak Shivakoti, Nikhil Gupte, Wei-Teng Yang, Noluthando Mwelase, Cecilia Kanyama, Alice M. Tang, Sandy Pillay, Wadzanai Samaneka, Cynthia Riviere, Sima Berendes, Javier R. Lama, Sandra W. Cardoso, Patcharaphan Sugandhavesa, Richard D. Semba, Parul Christian, Thomas B. Campbell, Amita Gupta“... (incident World Health Organization (WHO) stage 3, 4 or death by 96 weeks) or virologic failure by 24...”
Published 2014-11-01
Get full text
Article -
9by Tatsuya Ide, Yuichiro Eguchi, Masaru Harada, Kunihide Ishii, Masaru Morita, Yasuyo Morita, Gen Sugiyama, Hirofumi Fukushima, Yoichi Yano, Kazunori Noguchi, Hiroki Nakamura, Junjiro Hisatomi, Hiroto Kumemura, Miki Shirachi, Shinji Iwane, Michiaki Okada, Yuichi Honma, Teruko Arinaga-Hino, Ichiro Miyajima, Kei Ogata, Reiichiro Kuwahara, Keisuke Amano, Toshihiro Kawaguchi, Ryoko Kuromatsu, Takuji Torimura, DAAs Multicenter Study Group“... asunaprevir (200 mg/day) was given for 24 weeks. The virological responses and resistance-associated...”
Published 2016-01-01
Get full text
Article -
10by Andre Minhoto Lanca, Jeova Keny Baima Collares, João Leandro de Paula Ferreira, Danielle Malta Lima, Luis Fernando de Macedo Brigido, Rosangela Rodrigues, Benedito Antonio Lopes da Fonseca“... weeks. Similar virological and immunological responses were observed for both treatment regimens. The 43...”
Published 2012-02-01
Get full text
Article -
11by Pin-Nan Cheng, Chi-Yi Chen, Ming-Lung Yu, Chun-Che Lin, Chun-Yen Lin, Cheng-Yuan Peng, Kuo-Chih Tseng, Ching-Chu Lo, I-Hao Tseng, Chun-Jen Liu“... at least 4-week medication. Virologic failure was recorded as breakthrough, nonresponse, or relapse. Safety...”
Published 2021-08-01
Get full text
Article -
12by Sung Yong Han, Hyun Young Woo, Jeong Heo, Sang Gyu Park, Sung Ik Pyeon, Young Joo Park, Dong Uk Kim, Gwang Ha Kim, Hyung Hoi Kim, Geun Am Song, Mong Cho“... patients with HCV GT2 with/without cirrhosis were treated with SOF/RBV for 16/12 weeks. Rapid virological...”
Published 2021-05-01
Get full text
Article -
13by Rajiv Mehta, Mayank Kabrawala, Subhash Nandwani, Rini Tekriwal, Payal Nandania“... regimen (SOF and RBV) for either 12 or 24 weeks. The virological responses were obtained at baseline...”
Published 2017-03-01
Get full text
Article -
14by Tatiana Petukhova, Davor Ojkic, Beverly McEwen, Rob Deardon, Zvonimir Poljak“... of sensitivity than the ARIMA and GLARMA models. The number of weekly positive virological submissions...”
Published 2018-01-01
Get full text
Article -
15by Meng-Hsuan Hsieh, Ming-Lun Yeh, Tung-Hung Su, Ta-Wei Liu, Chuang-Feng Huang, Ching-I. Huang, Shu-Chi Wang, Jee-Fu Huang, Chia-Yen Dai, Jia-Horng Kao, Wan-Long Chuang, Pei-Jer Chen, Chun-Jen Liu, Ming-Lung Yu“... terminated treatment early due to adverse events (one at week 4, one at week 46), virological failures (one...”
Published 2018-06-01
Get full text
Article -
16“... response at week 4. Virologic response at end of treatment and sustained virologic response at 12 weeks...”
Get full text
Article -
17by Patricia Echeverría, Anna Bonjoch, Jordi Puig, José Moltó, Roger Paredes, Guillem Sirera, Arelly Ornelas, Nuria Pérez-Álvarez, Bonaventura Clotet, Eugènia Negredo“...-based regimen to a once-daily combination based on ETR maintained undetectable VL during 48 weeks...”
Published 2014-01-01
Get full text
Article -
18by Peter Vickerman, Hannah Fraser, April M Young, Jennifer R Havens, Takako Schaninger, Michelle Lofwall, Michele Staton, Ardis Hoven, Sharon L Walsh“... and self-report), side effects and engagement in risk behaviours. Post-treatment visits occur at 12 weeks...”
Published 2021-07-01
Get full text
Article -
19by Carlo Smirne, Antonio D'Avolio, Mattia Bellan, Alessandro Gualerzi, Maria G. Crobu, Mario Pirisi“... was 13.9 mg/kg/day, and therapy duration was 16 weeks. Sustained virological response (SVR) rates were 93.8...”
Published 2021-08-01
Get full text
Article -
20by Mohamed DA Abd Alla, Amer AA Gomaa, Galal A Abou Farrag, Mohamed G Shikhroho, Walid M Mousa, Osama AM Mahmoud“...% reported 12-week sustained virologic response (SVR) after treatment for 84 days. The current study goals...”
Published 2018-01-01
Get full text
Article